PAT Solutions > Blending
Blend Uniformity Analyzer

·         Highest resolution - 0.8nm with 1024 element array!

·         Fast - non-scanning device, acquire full spectrum in a millisecond!

·         Wireless and battery operated!

·         Self-referencing and self-calibrating!

In September of 2004, the FDA published a guidance document, “ PAT – A Framework for Innovative Pharmaceutical Development, Manufacturing and Quality Assurance.”  PAT is “ a system for designing, analyzing, and controlling manufacturing through timely measurement (i.e. during processing) of critical quality and performance attributes of raw and in-process materials and processes with the goal of ensuring final product quality”.

The current practice of blending for a pre-determined amount of time does not take into account physical differences in raw materials (e.g. excipients) like particle shape, size distribution, inter- and intra-particulate bonding, or humidity in the environment.  CDI Pharma’s Blend Analyzer provides information related to both physical (e.g. particle size, morphic form, moisture content) and chemical attributes.  It addresses limitations of time defined end points.  The end point can now be determined based on the desired attributes of the materials necessary for the next unit operation, i.e. blend is homogenous and uniform.

Benefits of Real-Time Control

  • Get it right every time
  • Reduced scrap and improved yield
  • Improved product quality
  • Fast analysis at point of manufacture speeds time to market and reduces inventory
  • Measurements are non-invasive and allow measurements of hazardous materials
  • Minimal operator involvement
  • Low maintenance

Product Specifications

 

Spectrometer

Optics

f/2 or f/3

 

Detector Options and Resolution

Type

Standard InGaAs
Single Stage T.E. Cooled

Extended InGaAs
Dual Stage T.E. Cooled

WavelengthRange

900nm to 1700nm

1100nm to 2200nm

Number of elements

256              

512

1024

256

512

Resolution (nm/pixel)

3.25

1.6

0.8

4.4

2.2

 

Data Acquisition

Electronics

16 Bit A/D, 330 Khz

Read out speed

0.7 ms per spectrum for 256 element array

 

Probe Head

Working Distance

Up to 25 mm from window

Sensing Area

25 mm

Light Source

Dual Tungsten Halogen Lamps, 5.4 watts each

Lifetime of Lamps

~9,000.00 hours each

 

Communications

Protocol

802.11 G Wireless Ethernet

 

Battery

Type

Li-Ion

Life

~3.5 hrs.

Changer

Built in

 

Auto Calibration

Wavelength Reference

Mercury-Argon line source

White Reference

Spectralon

 

USP <1119> Specifications (Sensor meets or exceeds the following)

Baseline Noise

<0.3 X 10-3 for high light flux

<1 X 10-3 for low light flux

Photometric Accuracy

+/- 1%for all levels

Wavelength Accuracy

NIST SRM 1920

or equivalent

+/- 1nm

Physical

Dimensions

14.95"L X 7.90"W X 6.75"H

379.731. mm X 200.66W mm X 171.45H mm

Weight

19.19 Ibs, 8.7 Kg

Housing

Class I,Div 11, EP available

 

Documentation

I/Q and O/Q documentation Included

 

Software

BlendSpekTM

PharmaSpekTM

Spec32TM

 

Warranty and Support

Warranty

1 year

Extended Warranty

Available

Support

Several support packages available

Telephone

CDI Pharma Help Desk

 

About CDI Pharma

CDI Pharma is a division of Control Development, Inc.  The division was formed to serve the unique needs of the pharmaceutical industry.  Control Development, Inc., an instrument and sensor maker has a 15-year history of innovation in dynamic process analysis.  We are one of the largest producers of NIR-diode array-based spectrometers today, with over 1,000 systems in place globally.

“All our sensors are diode array-based, and we pride ourselves as the premier manufacturer of such systems.”

CDI Pharma products include a battery-powered and wireless-transmitting NIR blend uniformity analyzer designed for PAT applications.  The monitor is contaminant-resistant and has a very high optical efficiency.  Our product is already in use at several pharmaceutical sites.  The division’s software suite includes PharmaSpek™ and BlendSpek™, with their 21CFCR11 ready cores tailored for specific blender, granulator, coater and dryer interface requirements.

CDI Pharma has trained its staff to professional pharmaceutical standards, instituted GMP-compatible qualification packages, and has instituted audit-ready software support programs.

Our Technology

Self-calibrating probe head and sampling system

We have patents pending (worldwide) on our sampling and illumination system.  Our unique design enhances performance, while increasing ruggedness at the same time.

  • Sample is illuminated by dual tungsten halogen lamps
  • Large 25 mm diameter sample area
  • Working distance up to 25mm from window
  • Sapphire double meniscus window reduces back reflection
  • Spectralon white reference plate
  • Hg-Ar wavelength calibration source
  • Fiber optic pickup

Click for a large view

Click here for a large view 

All our NIR spectrometer sensor systems use T. E. cooled InGaAs diode arrays.  InGaAs array performance and packaging has improved over the last 10 years to meet the stringent requirements of the telecommunications industry and are now available to the pharmaceutical industry.

 

These devices feature:

·        Wide dynamic range

·        Low noise and low dark current

·     Selectable gain

·        Anti-saturation circuitry

·        Correlated double sampling circuitry (greatly reduces reset noise)

·        Offset compensation circuit

·        Low cross talk

·      High resolution

·        Thermo-electric cooling, single stage for standard InGaAs detectors and dual stage for extended InGaAs detectors

Click here to download a PDF file of this product
Part Number:  BM-1000

Next Page

  Printer friendly versionPrinter friendly version

Updated on: Tuesday July 08, 2008 Est